AXS 2X PFE Bull Daily ETF (PFEL) News

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday...

Dexcom Expands AID Partnership Into The Netherlands

The world’s most connected continuous glucose monitoring system‡, Dexcom G6, now connects with the Omnipod® 5 Automated Insulin Delivery (AID...

Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes

Dexcom unveils more clinical data reaffirming the benefits of Dexcom CGM use among people with Type 2 diabetes than at any previous ADA...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Dexcom G7 Now Connects Directly to Apple Watch in the U.S.

Diabetes management goes hands-free as Dexcom G7 now connects directly to Apple Watch* in the U.S., giving...

Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant...

Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities